Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Jackisch

Showing results (51-60 of 231) with videos related to

Pageof 24
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 24, 2017
Primary metastatic breast cancer in the era of targeted therapy - Prognostic impact and the role of breast tumour surgeryJana Barinoff, Marcus Schmidt, Andreas Schneeweiss, et al.
Breast Care (Basel, Switzerland)|February 19, 2026
Treatment Experience of Early-Stage Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer in a Real-World Setting: European Patients' PerspectivesMaggie Banys-Paluchowski, Diana Lüftner, Agnieszka Korfel, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 20, 2006
Neutropenic event risk and impaired chemotherapy delivery in six European audits of breast cancer treatmentMatthias Schwenkglenks, Christian Jackisch, Manuel Constenla, et al.
Breast Care (Basel, Switzerland)|March 5, 2011
Adherence to Treatment Guidelines in Breast Cancer Care - a Retrospective Analysis of the 'Organgruppe Mamma der Arbeitsgemeinschaft Gynaekologische Onkologie'Christian Jackisch, Michael Untch, Dimitrios Chatsiproios, et al.
Geburtshilfe Und Frauenheilkunde|October 3, 2022
Advanced Breast Cancer: AGO Recommendations 2022 - Focus on ABC6 ConsensusMichael Untch, Peter A Fasching, Renate Haidinger, et al.
Breast Care (Basel, Switzerland)|March 31, 2022
ABC6 Consensus: Assessment by a Group of German ExpertsDiana Lüftner, Peter A Fasching, Renate Haidinger, et al.
Oncology Research and Treatment|August 17, 2018
Implementation of a Systematic Literature Search Strategy in a National Breast Cancer Guideline: The Relevance of Systemic Therapy in Lymph Node Recurrent DiseaseTanja N Stüber, Stephanie Stangl, Christian Jackisch, et al.
Geburtshilfe Und Frauenheilkunde|October 11, 2021
AGO Algorithms for the Treatment of Breast Cancer: Update 2021Andreas Schneeweiss, Peter A Fasching, Tanja Fehm, et al.
The Lancet. Oncology|August 14, 2012
Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I-III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trialGustavo Ismael, Roberto Hegg, Susanne Muehlbauer, et al.
JAMA Oncology|April 19, 2019
Subcutaneous vs Intravenous Trastuzumab for Patients With ERBB2-Positive Early Breast Cancer: Final Analysis of the HannaH Phase 3 Randomized Clinical TrialChristian Jackisch, Daniil Stroyakovskiy, Xavier Pivot, et al.
Pageof 24

Showing results (51-60 of 231) with videos related to

Sort By:
Pageof 24
European Journal of Cancer (Oxford, England : 1990)|July 24, 2017
Primary metastatic breast cancer in the era of targeted therapy - Prognostic impact and the role of breast tumour surgeryJana Barinoff, Marcus Schmidt, Andreas Schneeweiss, et al.
Breast Care (Basel, Switzerland)|February 19, 2026
Treatment Experience of Early-Stage Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer in a Real-World Setting: European Patients' PerspectivesMaggie Banys-Paluchowski, Diana Lüftner, Agnieszka Korfel, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 20, 2006
Neutropenic event risk and impaired chemotherapy delivery in six European audits of breast cancer treatmentMatthias Schwenkglenks, Christian Jackisch, Manuel Constenla, et al.
Breast Care (Basel, Switzerland)|March 5, 2011
Adherence to Treatment Guidelines in Breast Cancer Care - a Retrospective Analysis of the 'Organgruppe Mamma der Arbeitsgemeinschaft Gynaekologische Onkologie'Christian Jackisch, Michael Untch, Dimitrios Chatsiproios, et al.
Geburtshilfe Und Frauenheilkunde|October 3, 2022
Advanced Breast Cancer: AGO Recommendations 2022 - Focus on ABC6 ConsensusMichael Untch, Peter A Fasching, Renate Haidinger, et al.
Breast Care (Basel, Switzerland)|March 31, 2022
ABC6 Consensus: Assessment by a Group of German ExpertsDiana Lüftner, Peter A Fasching, Renate Haidinger, et al.
Oncology Research and Treatment|August 17, 2018
Implementation of a Systematic Literature Search Strategy in a National Breast Cancer Guideline: The Relevance of Systemic Therapy in Lymph Node Recurrent DiseaseTanja N Stüber, Stephanie Stangl, Christian Jackisch, et al.
Geburtshilfe Und Frauenheilkunde|October 11, 2021
AGO Algorithms for the Treatment of Breast Cancer: Update 2021Andreas Schneeweiss, Peter A Fasching, Tanja Fehm, et al.
The Lancet. Oncology|August 14, 2012
Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I-III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trialGustavo Ismael, Roberto Hegg, Susanne Muehlbauer, et al.
JAMA Oncology|April 19, 2019
Subcutaneous vs Intravenous Trastuzumab for Patients With ERBB2-Positive Early Breast Cancer: Final Analysis of the HannaH Phase 3 Randomized Clinical TrialChristian Jackisch, Daniil Stroyakovskiy, Xavier Pivot, et al.
Pageof 24